ANTINUCLEAR ANTIBODY (ANA) - ANVISA Registration 10338930304

Access comprehensive regulatory information for ANTINUCLEAR ANTIBODY (ANA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10338930304 and manufactured by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including INOVA DIAGNOSTICS, INC., ORGENTEC DIAGNOSTIKA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10338930304
Registration Details
ANVISA Registration Number: 10338930304
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

IIFT: Crithidia luciliae (anti-dsDNA)
Risk Class II

Registration Details

10338930304

25351840065202336

93741726000166

Company Information

Brazil
PT: BRASIL

Dates and Status

Jan 02, 2024

VIGENTE

09/18/2025 19:00:01